"The review has explored the question of accelerated access through four workstreams spanning the development pathway and a fifth focussing on patient engagement in all parts of the pathway. Each workstream has looked across issues concerning drugs, devices, diagnostics and digital health products."
Accelerated access review: Interim report: Review of innovative medicines and medical technologies, supported by Wellcome Trust
October 2015
Read more here.
QIPP stands for Quality, Innovation, Productivity and Prevention. The aim of this initiative is to help health care organisations deliver higher quality care and operate more efficiently and effectively.
Showing posts with label devices. Show all posts
Showing posts with label devices. Show all posts
Thursday, 29 October 2015
Review of innovative medicines and medical technologies
Labels:
change management,
devices,
diagnostics,
digital health products,
drugs,
engagement,
innovation,
medicines,
patient-centred care,
technology
Saturday, 15 October 2011
Challenges to value-enhancing innovation in health care delivery
"Limiting the growth of health care costs while improving population health is perhaps the most important and difficult challenge facing U.S. health policymakers."
Challenges to value-enhancing innovation in health care delivery: commonalities and contrasts with innovation in drugs and devices
S Garber, SM Gates, ME Blume-Kohout, JR Burgdorf, H Wu
RAND
October 2011
Read more here.
Challenges to value-enhancing innovation in health care delivery: commonalities and contrasts with innovation in drugs and devices
S Garber, SM Gates, ME Blume-Kohout, JR Burgdorf, H Wu
RAND
October 2011
Read more here.
Labels:
devices,
drugs,
health care,
innovation,
value
Subscribe to:
Posts (Atom)